384
Views
6
CrossRef citations to date
0
Altmetric
Review

Embracing synthetic lethality of novel anticancer therapies

, &

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

M. Shahar Yar, Kashif Haider, Vivek Gohel, Nasir Ali Siddiqui & Ahmed Kamal. (2020) Synthetic lethality on drug discovery: an update on cancer therapy. Expert Opinion on Drug Discovery 15:7, pages 823-832.
Read now

Articles from other publishers (5)

Thoukhir B. Shaik, M. Shaheer Malik, Sunitha R. Routhu, Zaki S. Seddigi, Ismail I. Althagafi & Ahmed Kamal. (2020) Evaluation of Anticancer and Anti-Mitotic Properties of Quinazoline and Quinazolino-Benzothiadiazine Derivatives. Anti-Cancer Agents in Medicinal Chemistry 20:5, pages 599-611.
Crossref
Jabeena Khazir, Bilal Ahmad Mir, Meeshu Pandita, Lynne Pilcher, Darren Riley & Gousia Chashoo. (2020) Design and synthesis of sulphonyl acetamide analogues of quinazoline as anticancer agents. Medicinal Chemistry Research 29:5, pages 916-925.
Crossref
Erdem Coskun, Gamze Tuna, Pawel Jaruga, Alessandro Tona, Onur Erdem & Miral Dizdaroglu. (2019) Identification and quantification of DNA repair protein poly(ADP ribose) polymerase 1 (PARP1) in human tissues and cultured cells by liquid chromatography/isotope-dilution tandem mass spectrometry. DNA Repair 75, pages 48-59.
Crossref
Cyril Ronco, Anthony R. Martin, Luc Demange & Rachid Benhida. (2017) ATM, ATR, CHK1, CHK2 and WEE1 inhibitors in cancer and cancer stem cells. MedChemComm 8:2, pages 295-319.
Crossref
M.R. Kelley & M.L. Fishel. 2016. DNA Repair in Cancer Therapy. DNA Repair in Cancer Therapy 1 54 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.